Here are relevant reports on : clinical-next-generation-sequencing-ngs-market
-
Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029
The global next-generation sequencing market, valued at US$12.13 billion in 2023, stood at US$12.65 billion in 2024 and is projected to advance at a resilient CAGR of 13.2% from 2024 to 2029, culminating in a forecasted valuation of US$23.55 billion by the end of the period. The primary growth drivers of the next-generation sequencing market are the surge in the rising demand for precision medicine in identifying genetic mutations and biomarkers, enabling targeted therapies and advancing precision medicine initiatives globally.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Europe Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture)-Forecast to 2030
The Europe next-generation sequencing market is projected to reach USD 8.88 billion by 2030 from USD 4.42 billion in 2025, at a CAGR of 15.0% during the forecast period of 2025 to 2030. Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), and F. Hoffmann-La Roche (Switzerland),.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030
The Asia Pacific next-generation sequencing market is projected to reach USD 7.38 billion by 2030, up from USD 3.40 billion in 2025, with a significant CAGR of 16.7% during the forecast period of 2025 to 2030. The Key Players Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Wuxi Biologics (China), and Takara Bio (Japan).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
North America Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture)-Forecast to 2030
The North America next-generation sequencing market is expected to grow from USD 6.15 billion in 2025 to USD 11.63 billion by 2030, at a compound annual growth rate (CAGR) of 13.6% during the forecast period. The key Players Illumina (US), Thermo Fisher Scientific (US), Roche (Switzerland), and Danaher (US).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029
The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Next-Generation Drug Conjugates (NDCs) Market - Global Forecast 2030
Next-generation drug conjugates (NDCs) are are an advanced class of targeted therapeutics designed to improve the specificity, efficacy, and safety of traditional drug conjugates. The NDCs market is mainly driven by factors such as need for more effective, targeted, and safer treatments in oncology and other therapeutic areas, growing innovation in targeting technology, payloads, linkers, and drug delivery systems, along with strong regulatory and clinical support.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Low power Next Generation Display Market (2009 - 2014)
This report highlights the basic structure of the low power consuming next generation display market and its various sub-segments. LCD displays have been taken as the benchmark for power consumption; and only those display technologies have been considered that consume lesser power than LCDs. These include electrochromic displays, electrophoretic displays, electrowetting, LED, OLED, FED (Field Emitting Displays) and electroluminescent and excluded CRT, LCD and plasma.
- Published: July 2009
- Price: $ 4950
- TOC Available:
-
Long Read Sequencing Market by Offerings (Consumables, Instruments, Services), Workflow (Sample Prep, Sequencing, Data Analysis), Technology (Nanopore, SMRT), Application (WGS, WES, Epigenetics), Usage (Clinical, Research) - Global Forecast to 2029
The global long-read sequencing market, valued at US$596 million in 2023, stood at US$758 million in 2024 and is projected to advance at a resilient CAGR of 32.8% from 2024 to 2029, culminating in a forecasted valuation of US$3,129 million by the end of the period. The main forces behind the growth of this market are the rising frequency of complex genetic disorders, expanding applications of long-read sequencing, and the technological development in genome sequencing aiding in the adoption of third-generation sequencing.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Global Forecast to 2028
The global microbiome sequencing services market, valued at US$250 million in 2022, stood at US$284 million in 2023 and is projected to advance at a resilient CAGR of 14.3% from 2023 to 2028, culminating in a forecasted valuation of US$555 billion by the end of the period. Growth in this market is primarily driven by the increasing demand for metagenomic sequencing, the growing focus on the development of human microbiome therapeutics, and the high cost of advanced sequencing infrastructure.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.
- Published: October 2015
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
